Led by Athena Philis-Tsimikas, MD, the TrialNet team at Scripps Whittier Diabetes Institute is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Scripps Whittier Diabetes Institute is regionally overseen by University of California - San Francisco. If you reach out to TrialNet, you may be contacted by staff from either institution.